Description of the Clinical Case of Adalimumab and Secukinumab Therapy of a Patient with Psoriatic Arthritis

This article considers the relevance of treating psoriatic arthritis with genetically engineered drugs such as adalimumab and secukinumab. Also, it conducts retrospective analysis of the medical history of the patient, who had this therapy.

Bibliographic Details
Main Authors: V. V. Didenko, G. A. Kalashnik, Ju. Ju. Karpenko, E. N. Harlamova
Format: Article
Language:Russian
Published: SINAPS LLC 2021-05-01
Series:Arhivʺ Vnutrennej Mediciny
Subjects:
Online Access:https://www.medarhive.ru/jour/article/view/1239
id doaj-bd8233c5c7254eae81fba35006cfdc41
record_format Article
spelling doaj-bd8233c5c7254eae81fba35006cfdc412021-07-29T08:11:37ZrusSINAPS LLCArhivʺ Vnutrennej Mediciny2226-67042411-65642021-05-0111322522810.20514/2226-6704-2021-11-3-225-228846Description of the Clinical Case of Adalimumab and Secukinumab Therapy of a Patient with Psoriatic ArthritisV. V. Didenko0G. A. Kalashnik1Ju. Ju. Karpenko2E. N. Harlamova3State Budgetary Educational ln-stitution of High Professional Education «Voronezh State Medical University n.a. N.N. Burdenko» of the Ministry of Health of the Russian Federation, Department of Hospital Therapy and EndocrinologyState Budgetary Educational ln-stitution of High Professional Education «Voronezh State Medical University n.a. N.N. Burdenko» of the Ministry of Health of the Russian Federation, Department of Hospital Therapy and EndocrinologyState Budgetary Educational ln-stitution of High Professional Education «Voronezh State Medical University n.a. N.N. Burdenko» of the Ministry of Health of the Russian Federation, Department of Hospital Therapy and EndocrinologyState Budgetary Educational ln-stitution of High Professional Education «Voronezh State Medical University n.a. N.N. Burdenko» of the Ministry of Health of the Russian Federation, Department of Hospital Therapy and EndocrinologyThis article considers the relevance of treating psoriatic arthritis with genetically engineered drugs such as adalimumab and secukinumab. Also, it conducts retrospective analysis of the medical history of the patient, who had this therapy.https://www.medarhive.ru/jour/article/view/1239psoriatic arthritisgenetically engineered drugsadalimumabsecukinumab
collection DOAJ
language Russian
format Article
sources DOAJ
author V. V. Didenko
G. A. Kalashnik
Ju. Ju. Karpenko
E. N. Harlamova
spellingShingle V. V. Didenko
G. A. Kalashnik
Ju. Ju. Karpenko
E. N. Harlamova
Description of the Clinical Case of Adalimumab and Secukinumab Therapy of a Patient with Psoriatic Arthritis
Arhivʺ Vnutrennej Mediciny
psoriatic arthritis
genetically engineered drugs
adalimumab
secukinumab
author_facet V. V. Didenko
G. A. Kalashnik
Ju. Ju. Karpenko
E. N. Harlamova
author_sort V. V. Didenko
title Description of the Clinical Case of Adalimumab and Secukinumab Therapy of a Patient with Psoriatic Arthritis
title_short Description of the Clinical Case of Adalimumab and Secukinumab Therapy of a Patient with Psoriatic Arthritis
title_full Description of the Clinical Case of Adalimumab and Secukinumab Therapy of a Patient with Psoriatic Arthritis
title_fullStr Description of the Clinical Case of Adalimumab and Secukinumab Therapy of a Patient with Psoriatic Arthritis
title_full_unstemmed Description of the Clinical Case of Adalimumab and Secukinumab Therapy of a Patient with Psoriatic Arthritis
title_sort description of the clinical case of adalimumab and secukinumab therapy of a patient with psoriatic arthritis
publisher SINAPS LLC
series Arhivʺ Vnutrennej Mediciny
issn 2226-6704
2411-6564
publishDate 2021-05-01
description This article considers the relevance of treating psoriatic arthritis with genetically engineered drugs such as adalimumab and secukinumab. Also, it conducts retrospective analysis of the medical history of the patient, who had this therapy.
topic psoriatic arthritis
genetically engineered drugs
adalimumab
secukinumab
url https://www.medarhive.ru/jour/article/view/1239
work_keys_str_mv AT vvdidenko descriptionoftheclinicalcaseofadalimumabandsecukinumabtherapyofapatientwithpsoriaticarthritis
AT gakalashnik descriptionoftheclinicalcaseofadalimumabandsecukinumabtherapyofapatientwithpsoriaticarthritis
AT jujukarpenko descriptionoftheclinicalcaseofadalimumabandsecukinumabtherapyofapatientwithpsoriaticarthritis
AT enharlamova descriptionoftheclinicalcaseofadalimumabandsecukinumabtherapyofapatientwithpsoriaticarthritis
_version_ 1721257164128911360